General Electric is considering breakup options after taking a major tax hit related to an old portfolio of long-term care insurance.
FDA said it will delay implementing a rule put forth last year that would have changed how it determines the intended use of a medical product.
Lombard Medical Technologies has defaulted on a loan and said it doesn't have enough cash to survive past the first half of this year. Here's a look at how things went from bad to worse for Lombard.
Medtronic was one of four multinational companies chastised by Chinese regulators for referring to Taiwan as a country online.
FDA approved a new clinician programmer for the company's implantable pain pump, as well as a series of recent design changes aimed at improving the pump s a pain management device.
The company enrolled the first patient in a postmarket study of its Evolve workflow therapy to standardize guidance for physicians.
The developer seeks to introduce a low-cost, point-of-care test that could deliver quick results with the help of a smartphone app.
The new GOP tax law gives companies more flexibility when it comes to capital allocation, Johnson & Johnson's CFO says. Could that lead to an uptick in mergers and acquisitions among medical device and diagnostics companies?
During an on-stage interview with CNN's Sanjay Gupta, MD, at the J.P. Morgan Healthcare Conference, Bill Gates revealed several fun facts about himself, including the reason he will probably never run for president of the United States.
Baxter Healthcare released contaminated wastewater from its Round Lake, IL-based development facility into a tributary that flows into nearby Long Lake, according to a lawsuit filed by Illinois Attorney General Lisa Madigan.
Angiodynamics updated investors on its lawsuit against C.R. Bard, an effort the company launched last year to level the playing field in the PICC market.
Comments from a recent AAMI meeting on revising ANSI/AAMI PB70:2012 “Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities” reveal what changes could be in store for the standard.
FDA cleared Zimmer Biomet's Sidus Stem-Free Shoulder system for total shoulder arthroplasty in certain patients. The company got a new CEO just two weeks ago and is still working to address its manufacturing issues.